We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
+8.19%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.07%
AUM
$73.1B
AUM Growth
+$2.4B
Cap. Flow
-$1.43B
Cap. Flow %
-1.96%
Top 10 Hldgs %
11.25%
Holding
4,601
New
626
Increased
1,390
Reduced
2,018
Closed
524

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$839M
2
AMZN icon
Amazon
AMZN
+$810M
3
TSLA icon
Tesla
TSLA
+$644M
4
TSM icon
TSMC
TSM
+$546M
5
JNJ icon
Johnson & Johnson
JNJ
+$389M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$891M
2
HD icon
Home Depot
HD
+$441M
3
JPM icon
JPMorgan Chase
JPM
+$335M
4
NVO
Novo Nordisk
NVO
+$317M
5
ASML icon
ASML
ASML
+$315M

Sector Composition

Rank Sector Weight
1 Healthcare 20.81%
2 Technology 15.51%
3 Consumer Discretionary 11.84%
4 Consumer Staples 10.09%
5 Financials 9.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INFI
3351
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$233K ﹤0.01%
419,600
-251,012
-37% -$214K
DNTH icon
3352
Dianthus Therapeutics
DNTH
$6.15B
$232K ﹤0.01%
36,745
+11,442
+45% +$203K
VTEX icon
3353
VTEX
VTEX
$750M
$232K ﹤0.01%
61,900
+32,600
+111% +$124K
SCHV
3354
Schwab US Large-Cap Value ETF
SCHV
$16.1B
$231K ﹤0.01%
10,500
-27,900
-73% -$604K
PCYO icon
3355
Pure Cycle
PCYO
$255M
$230K ﹤0.01%
21,900
-37,100
-63% -$347K
REGL icon
3356
ProShares S&P MidCap 400 Dividend Aristocrats ETF
REGL
$1.81B
$229K ﹤0.01%
3,200
-300
-9% -$21.2K
RHP icon
3357
Ryman Hospitality Properties
RHP
$8.05B
$229K ﹤0.01%
+2,800
New +$240K
VTSI icon
3358
VirTra
VTSI
$34M
$229K ﹤0.01%
48,900
-14,200
-23% -$68.3K
CMLS
3359
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
$229K ﹤0.01%
36,900
-16,200
-31% -$116K
NOVN
3360
DELISTED
Novan, Inc. Common Stock
NOVN
$229K ﹤0.01%
156,674
-118,278
-43% -$139K
STSA
3361
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$229K ﹤0.01%
254,100
+244,100
+2,441% +$707K
MGYR icon
3362
Magyar Bancorp
MGYR
$124M
$227K ﹤0.01%
17,700
+4,343
+33% +$55.2K
RANI icon
3363
Rani Therapeutics
RANI
$87.7M
$227K ﹤0.01%
+38,400
New +$280K
BCEL
3364
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$227K ﹤0.01%
283,324
-122,553
-30% -$156K
GAIA icon
3365
Gaia
GAIA
$48.1M
$224K ﹤0.01%
93,946
+1,046
+1% +$2.59K
LVLU icon
3366
Lulu's Fashion Lounge
LVLU
$51.2M
$224K ﹤0.01%
5,947
+867
+17% +$58.4K
ALR
3367
DELISTED
AlerisLife Inc
ALR
$224K ﹤0.01%
406,600
-21,900
-5% -$18.2K
OVID icon
3368
Ovid Therapeutics
OVID
$489M
$223K ﹤0.01%
119,800
+1,000
+0.8% +$1.7K
VTYX
3369
DELISTED
Ventyx Biosciences
VTYX
$223K ﹤0.01%
6,800
+1,000
+17% +$29.6K
COCP icon
3370
Cocrystal Pharma
COCP
$14.1M
$222K ﹤0.01%
114,028
-19,674
-15% -$50.4K
IDEX
3371
DELISTED
Ideanomics, Inc. Common Stock
IDEX
$222K ﹤0.01%
10,844
+1,112
+11% +$32.3K
IYZ icon
3372
iShares US Telecommunications ETF
IYZ
$1.24B
$220K ﹤0.01%
+9,800
New +$219K
MLPX icon
3373
Global X MLP & Energy Infrastructure ETF
MLPX
$3.54B
$220K ﹤0.01%
+5,400
New +$222K
YQ
3374
17 Education & Technology Group
YQ
$19.5M
$220K ﹤0.01%
21,591
-560
-3% -$3.21K
GXC icon
3375
State Street SPDR S&P China ETF
GXC
$477M
$219K ﹤0.01%
+2,800
New +$203K

Similar funds

Renaissance Technologies's Q4 2022 Portfolio in Review

As of Q4 2022, Renaissance Technologies held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Renaissance Technologies's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Renaissance Technologies's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
  • Renaissance Technologies added most to Apple in Q4 2022, an estimated $839M increase.
  • Renaissance Technologies's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
  • Renaissance Technologies fully exited Microsoft in Q4 2022, selling an estimated $891M.
  • Renaissance Technologies's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
  • Renaissance Technologies opened 626 new positions and closed 524 in Q4 2022.
  • Renaissance Technologies's portfolio value rose 3.4% quarter-over-quarter to $73.1B.

Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.